Haegarda is a medication that is used to prevent attacks of hereditary angioedema (HAE) in patients who are 12 years of age and older. HAE is a rare genetic condition that causes episodes of swelling in various parts of the body, including the face, hands, feet, and gastrointestinal tract. These attacks can be painful, debilitating, and even life-threatening if not properly managed.

Haegarda works by replacing the missing or malfunctioning C1 inhibitor protein in patients with HAE. This protein helps regulate the body’s immune response and prevents the excessive release of chemicals that cause swelling. By restoring the levels of C1 inhibitor in the body, Haegarda can reduce the frequency and severity of HAE attacks.

It is important to follow your healthcare provider’s instructions when taking Haegarda. This medication is typically administered as a subcutaneous injection, which means it is injected under the skin. Your healthcare provider will show you how to properly administer the medication and may recommend a specific dosing schedule based on your individual needs.

Like any medication, Haegarda may cause side effects in some patients. Common side effects may include injection site reactions, headache, and nausea. It is important to report any unusual or severe side effects to your healthcare provider promptly.

Overall, Haegarda has been shown to be an effective and well-tolerated treatment for preventing HAE attacks. If you have been diagnosed with HAE, talk to your healthcare provider about whether Haegarda may be a suitable option for you. Remember, managing your condition effectively can help improve your quality of life and reduce the risk of complications associated with HAE.